| Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis ES Sotirchos, P Bhargava, C Eckstein, K Van Haren, M Baynes, A Ntranos, ... Neurology 86 (4), 382-390, 2016 | 174 | 2016 |
| Disease-modifying therapies alter gut microbial composition in MS I Katz Sand, Y Zhu, A Ntranos, JC Clemente, E Cekanaviciute, ... Neurology: Neuroimmunology & Neuroinflammation 6 (1), e517, 2018 | 99 | 2018 |
| Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells IV Grishkan, A Ntranos, PA Calabresi, AR Gocke Cellular immunology 284 (1-2), 68-74, 2013 | 62 | 2013 |
| Bromodomains: Translating the words of lysine acetylation into myelin injury and repair A Ntranos, P Casaccia Neuroscience letters 625, 4-10, 2016 | 61 | 2016 |
| FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway A Ntranos, O Hall, DP Robinson, IV Grishkan, JT Schott, DM Tosi, ... Journal of neuroimmunology 270 (1-2), 13-21, 2014 | 55 | 2014 |
| Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma A Ntranos, HJ Park, M Wentling, V Tolstikov, M Amatruda, B Inbar, ... Brain 145 (2), 569-583, 2022 | 51 | 2022 |
| Diagnostic criteria, classification and treatment goals in multiple sclerosis: the chronicles of time and space A Ntranos, F Lublin Current neurology and neuroscience reports 16, 1-8, 2016 | 46 | 2016 |
| The microbiome–gut–behavior axis: crosstalk between the gut microbiome and oligodendrocytes modulates behavioral responses A Ntranos, P Casaccia Neurotherapeutics 15 (1), 31-35, 2018 | 44 | 2018 |
| A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis M Wentling, C Lopez-Gomez, HJ Park, M Amatruda, A Ntranos, J Aramini, ... Brain 142 (9), 2756-2774, 2019 | 39 | 2019 |
| Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course K Castro, A Ntranos, M Amatruda, M Petracca, P Kosa, EY Chen, ... EBioMedicine 43, 392-410, 2019 | 39 | 2019 |
| Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases KM Mullen, AR Gocke, R Allie, A Ntranos, IV Grishkan, C Pardo, ... Journal of neuroimmunology 249 (1-2), 86-92, 2012 | 34 | 2012 |
| Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis A Ntranos, V Ntranos, V Bonnefil, J Liu, S Kim-Schulze, Y He, Y Zhu, ... Brain 142 (3), 647-661, 2019 | 23 | 2019 |
| Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’ A Harel, D Sperling, M Petracca, A Ntranos, I Katz-Sand, S Krieger, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (9), 977-982, 2018 | 18 | 2018 |
| High-dose vitamin D supplementation reduces IL-17-producing CD4+ T-cells and effector-memory CD4+ T-cells in multiple sclerosis patients (S38. 001) P Bhargava, E Sotirchos, C Eckstein, A Ntranos, A Gocke, E Mowry, ... Neurology 84 (14_supplement), S38. 001, 2015 | 11 | 2015 |
| Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis MG Kiss, JE Mindur, AG Yates, D Lee, JF Fullard, A Anzai, WC Poller, ... Immunity 56 (7), 1502-1514. e8, 2023 | 7 | 2023 |
| Education Research: Resident education through adult learning in neurology: Implementation and impact H Shoirah, A Ntranos, R Brandstadter, Y Liu, E Medina, J Kwan, S Krieger Neurology 91 (5), 234-238, 2018 | 7 | 2018 |
| Fatigue in early multiple sclerosis and the role of the caudate nucleus.(P4. 412) A Ntranos, S Krieger, M Fabian, V Leavitt, C Lewis, G Pelle, M El Mendili, ... Neurology 90 (15 Supplement), 2018 | 4 | 2018 |
| Author response: Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegia A Ntranos, H Shoirah, MS Dhamoon, D Hahn, TP Naidich, S Shin Neurology 89 (9), 979-979, 2017 | 2 | 2017 |
| Clinical Reasoning: a young woman with respiratory failure, hearing loss, and paraplegia A Ntranos, H Shoirah, MS Dhamoon, D Hahn, TP Naidich, S Shin Neurology 88 (10), e78-e84, 2017 | 2 | 2017 |
| Immunosurveillance of CCR6+ T-cells predicts treatment response to dimethyl-fumarate: implications for personalized treatment strategies in multiple sclerosis C Alifieris, SK Schultze, IK Sand, P Casaccia, A Ntranos medRxiv, 2020.05. 15.20102137, 2020 | 1 | 2020 |
